Sign Out
Care should be taken when alfuzosin is administered to patients who have experienced marked hypotension following administration of another alpha-1 blocker.
In patients with coronary disease, alfuzosin should not be prescribed alone.
The specific coronary insufficiency treatment should be continued. If angina pectoris recurs or worsens, alfuzosin treatment should be discontinued.
Patients must be informed that the tablets must be swallowed whole. The tablets must not be crunched, chewed, crushed or ground into a powder.
Doing so could lead to inappropriate release and absorption of the medicinal product consequently causing unwanted effects which may be of early onset.
Effects on ability to drive and use machines: Caution is required when driving vehicles or using machines due to the risks of postural hypotension, dizziness, asthenia, visual disturbances, especially at the start of treatment with alfuzosin.
